ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01866319
Brief Title: Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

First Submitted : May 28, 2013
First Submitted that Met QC Criteria : May 28, 2013
First Posted : May 31, 2013 (Estimate)

Results First Submitted : December 9, 2015
Results First Submitted that Met QC Criteria : December 9, 2015
Results First Posted : January 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 12, 2018
Last Update Posted : July 10, 2018